TRACON Pharmaceuticals, Inc. Research and Development Expense
TRACON Pharmaceuticals, Inc. reported Research and Development Expense of $1.35 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-08-13
- TRACON Pharmaceuticals, Inc. research and development expense for the quarter ending 2024-06-30 was $1.35M, a 61.30% decline year-over-year.
- TRACON Pharmaceuticals, Inc. research and development expense for the quarter ending 2024-03-31 was $1.88M, a 62.21% decline year-over-year.
- TRACON Pharmaceuticals, Inc. research and development expense for the quarter ending 2023-12-31 was $1.49M, a 61.45% decline year-over-year.
- TRACON Pharmaceuticals, Inc. research and development expense for the quarter ending 2023-09-30 was $2.33M, a 43.23% decline year-over-year.
- TRACON Pharmaceuticals, Inc. research and development expense for fiscal 2023 was $12.28M, a 11.60% decline from fiscal 2022.
- TRACON Pharmaceuticals, Inc. research and development expense for fiscal 2022 was $13.89M, a 24.60% increase from fiscal 2021.
- TRACON Pharmaceuticals, Inc. research and development expense for fiscal 2021 was $11.15M, a 35.96% increase from fiscal 2020.
- TRACON Pharmaceuticals, Inc. research and development expense for fiscal 2020 was $8.20M, a 43.58% decline from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.35M 10-Q · filed 2024-08-13 | $3.23M 10-Q · filed 2024-08-13 | $4.72M derived: sum of 3 quarters · filed 2024-08-13 | $7.05M derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $1.88M 10-Q · filed 2024-05-14 | $3.37M derived: sum of 2 quarters · filed 2024-05-14 | $5.70M derived: sum of 3 quarters · filed 2024-05-14 | $9.19M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $3.82M derived: sum of 2 quarters · filed 2024-03-05 | $7.31M derived: sum of 3 quarters · filed 2024-08-13 | $12.28M 10-K · filed 2024-03-05 |
| 2023-09-30 | $2.33M 10-Q · filed 2023-11-09 | $5.81M derived: sum of 2 quarters · filed 2024-08-13 | $10.78M 10-Q · filed 2023-11-09 | $14.66M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $3.49M 10-Q · filed 2024-08-13 | $8.46M 10-Q · filed 2024-08-13 | $12.33M derived: sum of 3 quarters · filed 2024-08-13 | $16.43M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.97M 10-Q · filed 2024-05-14 | $8.84M derived: sum of 2 quarters · filed 2024-05-14 | $12.94M derived: sum of 3 quarters · filed 2024-05-14 | $15.86M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $7.97M derived: sum of 2 quarters · filed 2024-03-05 | $10.89M derived: sum of 3 quarters · filed 2024-03-05 | $13.89M 10-K · filed 2024-03-05 |
| 2022-09-30 | $4.10M 10-Q · filed 2023-11-09 | $7.02M derived: sum of 2 quarters · filed 2023-11-09 | $10.01M 10-Q · filed 2023-11-09 | $13.08M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $2.92M 10-Q · filed 2023-08-14 | $5.92M 10-Q · filed 2023-08-14 | $8.98M derived: sum of 3 quarters · filed 2024-03-05 | $11.71M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $2.99M 10-Q · filed 2023-05-10 | $6.06M derived: sum of 2 quarters · filed 2024-03-05 | $8.79M derived: sum of 3 quarters · filed 2024-03-05 | $11.86M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $5.79M derived: sum of 2 quarters · filed 2024-03-05 | $8.86M derived: sum of 3 quarters · filed 2024-03-05 | $11.15M 10-K · filed 2024-03-05 |
| 2021-09-30 | $2.73M 10-Q · filed 2022-11-14 | $5.80M derived: sum of 2 quarters · filed 2022-11-14 | $8.08M 10-Q · filed 2022-11-14 | $10.28M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $3.07M 10-Q · filed 2022-08-10 | $5.35M 10-Q · filed 2022-08-10 | $7.55M derived: sum of 3 quarters · filed 2023-03-08 | $9.33M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $2.28M 10-Q · filed 2022-05-11 | $4.48M derived: sum of 2 quarters · filed 2023-03-08 | $6.27M derived: sum of 3 quarters · filed 2023-03-08 | $8.48M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $3.98M derived: sum of 2 quarters · filed 2023-03-08 | $6.20M derived: sum of 3 quarters · filed 2023-03-08 | $8.20M 10-K · filed 2023-03-08 |
| 2020-09-30 | $1.78M 10-Q · filed 2021-11-03 | $4.00M derived: sum of 2 quarters · filed 2021-11-03 | $6.00M 10-Q · filed 2021-11-03 | $7.91M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $2.22M 10-Q · filed 2021-08-11 | $4.22M 10-Q · filed 2021-08-11 | $6.13M derived: sum of 3 quarters · filed 2022-03-15 | $9.19M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-05 | $3.91M derived: sum of 2 quarters · filed 2022-03-15 | $6.97M derived: sum of 3 quarters · filed 2022-03-15 | $11.31M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.97M derived: sum of 2 quarters · filed 2022-03-15 | $9.32M derived: sum of 3 quarters · filed 2022-03-15 | $14.53M 10-K · filed 2022-03-15 |
| 2019-09-30 | $3.06M 10-Q · filed 2020-11-10 | $7.40M derived: sum of 2 quarters · filed 2020-11-10 | $12.62M 10-Q · filed 2020-11-10 | $18.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $4.35M 10-Q · filed 2020-08-05 | $9.56M 10-Q · filed 2020-08-05 | $15.49M derived: sum of 3 quarters · filed 2021-02-25 | $22.47M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $5.21M 10-Q · filed 2020-05-13 | $11.14M derived: sum of 2 quarters · filed 2021-02-25 | $18.12M derived: sum of 3 quarters · filed 2021-02-25 | $26.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.91M derived: sum of 2 quarters · filed 2021-02-25 | $21.02M derived: sum of 3 quarters · filed 2021-02-25 | $30.46M 10-K · filed 2021-02-25 |
| 2018-09-30 | $6.98M 10-Q · filed 2019-11-05 | $15.09M derived: sum of 2 quarters · filed 2019-11-05 | $24.53M 10-Q · filed 2019-11-05 | $29.15M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $8.12M 10-Q · filed 2019-08-07 | $17.55M 10-Q · filed 2019-08-07 | $22.18M derived: sum of 3 quarters · filed 2020-02-28 | $26.43M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $9.44M 10-Q · filed 2019-05-14 | $14.06M derived: sum of 2 quarters · filed 2020-02-28 | $18.32M derived: sum of 3 quarters · filed 2020-02-28 | $23.21M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $8.88M derived: sum of 2 quarters · filed 2020-02-28 | $13.77M derived: sum of 3 quarters · filed 2020-02-28 | $19.36M 10-K · filed 2020-02-28 |
| 2017-09-30 | $4.26M 10-Q · filed 2018-11-07 | $9.15M derived: sum of 2 quarters · filed 2018-11-07 | $14.73M 10-Q · filed 2018-11-07 | $19.50M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $4.89M 10-Q · filed 2018-08-08 | $10.47M 10-Q · filed 2018-08-08 | $15.24M derived: sum of 3 quarters · filed 2019-03-01 | $19.77M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $5.58M 10-Q · filed 2018-05-10 | $10.35M derived: sum of 2 quarters · filed 2019-03-01 | $14.88M derived: sum of 3 quarters · filed 2019-03-01 | $21.65M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $9.30M derived: sum of 2 quarters · filed 2019-03-01 | $16.07M derived: sum of 3 quarters · filed 2019-03-01 | $21.57M 10-K · filed 2019-03-01 |
| 2016-09-30 | $4.53M 10-Q · filed 2017-11-07 | $11.30M derived: sum of 2 quarters · filed 2017-11-07 | $16.80M 10-Q · filed 2017-11-07 | $27.36M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $6.77M 10-Q · filed 2017-08-08 | $12.27M 10-Q · filed 2017-08-08 | $22.83M derived: sum of 3 quarters · filed 2018-03-01 | $28.71M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $5.50M 10-Q · filed 2017-05-10 | $16.05M derived: sum of 2 quarters · filed 2018-03-01 | $21.94M derived: sum of 3 quarters · filed 2018-03-01 | $27.34M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $10.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $16.44M derived: sum of 2 quarters · filed 2018-03-01 | $21.85M derived: sum of 3 quarters · filed 2018-03-01 | $25.68M 10-K · filed 2018-03-01 |
| 2015-09-30 | $5.88M 10-Q · filed 2016-11-09 | $11.29M derived: sum of 2 quarters · filed 2016-11-09 | $15.12M 10-Q · filed 2016-11-09 | $17.68M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $5.41M 10-Q · filed 2016-08-11 | $9.24M 10-Q · filed 2016-08-11 | $11.80M derived: sum of 3 quarters · filed 2017-03-01 | $14.07M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $3.83M 10-Q · filed 2016-05-11 | $6.39M derived: sum of 2 quarters · filed 2017-03-01 | $8.66M derived: sum of 3 quarters · filed 2017-03-01 | $10.22M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.83M derived: sum of 2 quarters · filed 2017-03-01 | $6.39M derived: sum of 3 quarters · filed 2017-03-01 | $7.65M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.27M 10-Q · filed 2015-11-04 | $3.83M derived: sum of 2 quarters · filed 2015-11-04 | $5.09M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $1.56M 10-Q · filed 2015-08-06 | $2.82M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $1.26M 10-Q · filed 2015-05-14 | |||
| 2013-12-31 | $6.08M 10-K · filed 2016-02-19 |